Clarity2 Jun 2020 12:58
Had some time to digest:
1, This is the CDX work, the GlobalCo, Leukemia trials etc. This was always a slow process but we are years into it and next stage is phase 1 trials.
2, This does not at any point say 3 month DELAY. Its a 3 month EXTENSION to work together, you dont extend if things are not going well... REMEMBER it says EXTENSION not delay and things are going well.
3, We are still waiting on news from an ENTIRELY different game in terms of Orgenisis which is as major but seperate.
4, A leading global pharmaceutical company ("GlobalCo") engaged in the research, development, manufacture and marketing of pharmaceutical products is letting us use all their resources, FREE OF CHARGE and all its costing us so far is their anonymity. I am guessing they will expect favourable licencing rights at the end, happy with that!
5, Hemogenyx is NOT AIM nor is it a Covid-19 stock, it MAY help with Covid but thats not its aim, look at how they describe themselves: "Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The Company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development."
6, THERE ARE SHORTERS who have opened up a position to SHORT Hemogenyx because ALL They saw from that RNS was "OMG 3 months!! That must be a delay ppl will sell" THEY are manupulating the market and selling shares they dont hold in a hope to trigger selling, they deserve to be forced to close their position at a loss